Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03618979 · ClinicalTrials.gov registry record · NA
A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain
A NA study, sponsored by Regenexx.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03618979 is a NA study that was terminated before completion, run by Regenexx. The registered enrollment target is 8 participants.
The verdict
NCT03618979, a NA study, was terminated before completion, sponsored by Regenexx.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
To evaluate and compare the effectiveness of 3 different injection treatments on multifidus atrophy and lower back pain.
Interventions
- BIOLOGICAL PPP treatment
- BIOLOGICAL PRP treatment
- BIOLOGICAL PRP and PL Combo treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-05-02 |
| Est. Completion | 2022-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03618979
The ClinicalTrials.gov registry entry for NCT03618979 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Regenexx, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PPP treatment is the first listed.
NCT03618979 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03618979 about?
NCT03618979 is a clinical study titled "A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain". To evaluate and compare the effectiveness of 3 different injection treatments on multifidus atrophy and lower back pain.
What is the current status of trial NCT03618979?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2019-05-02. Estimated completion is 2022-06-29.
What interventions are being tested in trial NCT03618979?
The interventions under investigation include: PPP treatment (BIOLOGICAL), PRP treatment (BIOLOGICAL), PRP and PL Combo treatment (BIOLOGICAL).
Who is sponsoring clinical trial NCT03618979?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.